img

Global Human Alpha1-Proteinase Inhibitor Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Alpha1-Proteinase Inhibitor Market Insights, Forecast to 2034

Alpha1-Proteinase Inhibitor (Human), is a sterile, stable, lyophilized preparation of highly purified human alpha1-proteinase inhibitor (A1-PI)
Global Human Alpha1-Proteinase Inhibitor market is expected to reach to US$ 229 million in 2024, with a positive growth of %, compared with US$ 218 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Alpha1-Proteinase Inhibitor industry is evaluated to reach US$ 293.1 million in 2029. The CAGR will be 4.2% during 2024 to 2029.
The market growth can be attributed to several factors. Firstly, increasing awareness and improved diagnosis of AATD have led to a better identification of patients with this condition, driving the demand for Alpha1-PI therapy. Additionally, advancements in biotechnology and protein manufacturing techniques have contributed to the development of highly purified and more effective Alpha1-PI products, offering improved treatment options for patients.
Report Covers
This report presents an overview of global Human Alpha1-Proteinase Inhibitor market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Alpha1-Proteinase Inhibitor market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Kamada
Grifols
CSL Behring
Segment by Type
0.5g
1g

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Alpha1-Proteinase Inhibitor plant distribution, commercial date of Human Alpha1-Proteinase Inhibitor, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Alpha1-Proteinase Inhibitor introduction, etc. Human Alpha1-Proteinase Inhibitor Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Human Alpha1-Proteinase Inhibitor
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Alpha1-Proteinase Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 0.5g
1.2.3 1g
1.3 Market by Application
1.3.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Alpha1-Proteinase Inhibitor Sales Estimates and Forecasts 2018-2029
2.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Region
2.2.1 Global Human Alpha1-Proteinase Inhibitor Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2024)
2.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2024-2029)
2.2.4 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2018-2029)
2.3 Global Human Alpha1-Proteinase Inhibitor Sales Estimates and Forecasts 2018-2029
2.4 Global Human Alpha1-Proteinase Inhibitor Sales by Region
2.4.1 Global Human Alpha1-Proteinase Inhibitor Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Alpha1-Proteinase Inhibitor Sales by Region (2018-2024)
2.4.3 Global Human Alpha1-Proteinase Inhibitor Sales by Region (2024-2029)
2.4.4 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Alpha1-Proteinase Inhibitor Sales by Manufacturers
3.1.1 Global Human Alpha1-Proteinase Inhibitor Sales by Manufacturers (2018-2024)
3.1.2 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Alpha1-Proteinase Inhibitor in 2022
3.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers
3.2.1 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Alpha1-Proteinase Inhibitor Revenue in 2022
3.3 Global Key Players of Human Alpha1-Proteinase Inhibitor, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Alpha1-Proteinase Inhibitor Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Product Offered and Application
3.8 Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Alpha1-Proteinase Inhibitor Sales by Type
4.1.1 Global Human Alpha1-Proteinase Inhibitor Historical Sales by Type (2018-2024)
4.1.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
4.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Type
4.2.1 Global Human Alpha1-Proteinase Inhibitor Historical Revenue by Type (2018-2024)
4.2.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
4.3 Global Human Alpha1-Proteinase Inhibitor Price by Type
4.3.1 Global Human Alpha1-Proteinase Inhibitor Price by Type (2018-2024)
4.3.2 Global Human Alpha1-Proteinase Inhibitor Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Alpha1-Proteinase Inhibitor Sales by Application
5.1.1 Global Human Alpha1-Proteinase Inhibitor Historical Sales by Application (2018-2024)
5.1.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
5.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Application
5.2.1 Global Human Alpha1-Proteinase Inhibitor Historical Revenue by Application (2018-2024)
5.2.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
5.3 Global Human Alpha1-Proteinase Inhibitor Price by Application
5.3.1 Global Human Alpha1-Proteinase Inhibitor Price by Application (2018-2024)
5.3.2 Global Human Alpha1-Proteinase Inhibitor Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Alpha1-Proteinase Inhibitor Market Size by Type
6.1.1 US & Canada Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2029)
6.1.2 US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2029)
6.2 US & Canada Human Alpha1-Proteinase Inhibitor Market Size by Application
6.2.1 US & Canada Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2029)
6.2.2 US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2029)
6.3 US & Canada Human Alpha1-Proteinase Inhibitor Market Size by Country
6.3.1 US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Alpha1-Proteinase Inhibitor Sales by Country (2018-2029)
6.3.3 US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Alpha1-Proteinase Inhibitor Market Size by Type
7.1.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2029)
7.1.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2029)
7.2 Europe Human Alpha1-Proteinase Inhibitor Market Size by Application
7.2.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2029)
7.2.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2029)
7.3 Europe Human Alpha1-Proteinase Inhibitor Market Size by Country
7.3.1 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2018-2029)
7.3.3 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Alpha1-Proteinase Inhibitor Market Size
8.1.1 China Human Alpha1-Proteinase Inhibitor Sales (2018-2029)
8.1.2 China Human Alpha1-Proteinase Inhibitor Revenue (2018-2029)
8.2 China Human Alpha1-Proteinase Inhibitor Market Size by Application
8.2.1 China Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2029)
8.2.2 China Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Alpha1-Proteinase Inhibitor Market Size by Type
9.1.1 Asia Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2029)
9.1.2 Asia Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2029)
9.2 Asia Human Alpha1-Proteinase Inhibitor Market Size by Application
9.2.1 Asia Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2029)
9.2.2 Asia Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2029)
9.3 Asia Human Alpha1-Proteinase Inhibitor Sales by Region
9.3.1 Asia Human Alpha1-Proteinase Inhibitor Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2029)
9.3.3 Asia Human Alpha1-Proteinase Inhibitor Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Country
10.3.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Kamada
11.2.1 Kamada Company Information
11.2.2 Kamada Overview
11.2.3 Kamada Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Kamada Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Kamada Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grifols Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 CSL Behring
11.4.1 CSL Behring Company Information
11.4.2 CSL Behring Overview
11.4.3 CSL Behring Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 CSL Behring Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CSL Behring Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Alpha1-Proteinase Inhibitor Industry Chain Analysis
12.2 Human Alpha1-Proteinase Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Alpha1-Proteinase Inhibitor Production Mode & Process
12.4 Human Alpha1-Proteinase Inhibitor Sales and Marketing
12.4.1 Human Alpha1-Proteinase Inhibitor Sales Channels
12.4.2 Human Alpha1-Proteinase Inhibitor Distributors
12.5 Human Alpha1-Proteinase Inhibitor Customers
13 Market Dynamics
13.1 Human Alpha1-Proteinase Inhibitor Industry Trends
13.2 Human Alpha1-Proteinase Inhibitor Market Drivers
13.3 Human Alpha1-Proteinase Inhibitor Market Challenges
13.4 Human Alpha1-Proteinase Inhibitor Market Restraints
14 Key Findings in The Global Human Alpha1-Proteinase Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 0.5g
Table 3. Major Manufacturers of 1g
Table 4. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Human Alpha1-Proteinase Inhibitor Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2018-2024)
Table 9. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2024-2029)
Table 10. Global Human Alpha1-Proteinase Inhibitor Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2018-2024) & (K Units)
Table 12. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2024-2029) & (K Units)
Table 13. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2018-2024)
Table 14. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2024-2029)
Table 15. Global Human Alpha1-Proteinase Inhibitor Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Human Alpha1-Proteinase Inhibitor Sales Share by Manufacturers (2018-2024)
Table 17. Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Human Alpha1-Proteinase Inhibitor, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Human Alpha1-Proteinase Inhibitor Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Human Alpha1-Proteinase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Alpha1-Proteinase Inhibitor as of 2022)
Table 23. Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Product Offered and Application
Table 25. Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2024) & (K Units)
Table 28. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2024-2029) & (K Units)
Table 29. Global Human Alpha1-Proteinase Inhibitor Sales Share by Type (2018-2024)
Table 30. Global Human Alpha1-Proteinase Inhibitor Sales Share by Type (2024-2029)
Table 31. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2018-2024)
Table 34. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2024-2029)
Table 35. Human Alpha1-Proteinase Inhibitor Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Human Alpha1-Proteinase Inhibitor Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2024) & (K Units)
Table 38. Global Human Alpha1-Proteinase Inhibitor Sales by Application (2024-2029) & (K Units)
Table 39. Global Human Alpha1-Proteinase Inhibitor Sales Share by Application (2018-2024)
Table 40. Global Human Alpha1-Proteinase Inhibitor Sales Share by Application (2024-2029)
Table 41. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2018-2024)
Table 44. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2024-2029)
Table 45. Human Alpha1-Proteinase Inhibitor Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Human Alpha1-Proteinase Inhibitor Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Human Alpha1-Proteinase Inhibitor Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Human Alpha1-Proteinase Inhibitor Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Human Alpha1-Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Human Alpha1-Proteinase Inhibitor Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Human Alpha1-Proteinase Inhibitor Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Human Alpha1-Proteinase Inhibitor Sales by Country (2024-2029) & (K Units)
Table 60. Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2024) & (K Units)
Table 61. Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2024-2029) & (K Units)
Table 62. Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2024) & (K Units)
Table 65. Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2024-2029) & (K Units)
Table 66. Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Human Alpha1-Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2018-2024) & (K Units)
Table 72. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2024-2029) & (K Units)
Table 73. China Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2024) & (K Units)
Table 74. China Human Alpha1-Proteinase Inhibitor Sales by Type (2024-2029) & (K Units)
Table 75. China Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2024) & (K Units)
Table 78. China Human Alpha1-Proteinase Inhibitor Sales by Application (2024-2029) & (K Units)
Table 79. China Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2024) & (K Units)
Table 82. Asia Human Alpha1-Proteinase Inhibitor Sales by Type (2024-2029) & (K Units)
Table 83. Asia Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2024) & (K Units)
Table 86. Asia Human Alpha1-Proteinase Inhibitor Sales by Application (2024-2029) & (K Units)
Table 87. Asia Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Human Alpha1-Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Human Alpha1-Proteinase Inhibitor Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Human Alpha1-Proteinase Inhibitor Sales by Region (2018-2024) & (K Units)
Table 93. Asia Human Alpha1-Proteinase Inhibitor Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Country (2024-2029) & (K Units)
Table 107. Takeda Company Information
Table 108. Takeda Description and Major Businesses
Table 109. Takeda Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Takeda Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Takeda Recent Developments
Table 112. Kamada Company Information
Table 113. Kamada Description and Major Businesses
Table 114. Kamada Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Kamada Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Kamada Recent Developments
Table 117. Grifols Company Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Grifols Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. CSL Behring Company Information
Table 123. CSL Behring Description and Major Businesses
Table 124. CSL Behring Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. CSL Behring Human Alpha1-Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. CSL Behring Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Human Alpha1-Proteinase Inhibitor Distributors List
Table 130. Human Alpha1-Proteinase Inhibitor Customers List
Table 131. Human Alpha1-Proteinase Inhibitor Market Trends
Table 132. Human Alpha1-Proteinase Inhibitor Market Drivers
Table 133. Human Alpha1-Proteinase Inhibitor Market Challenges
Table 134. Human Alpha1-Proteinase Inhibitor Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Alpha1-Proteinase Inhibitor Product Picture
Figure 2. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Alpha1-Proteinase Inhibitor Market Share by Type in 2022 & 2029
Figure 4. 0.5g Product Picture
Figure 5. 1g Product Picture
Figure 6. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Human Alpha1-Proteinase Inhibitor Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Human Alpha1-Proteinase Inhibitor Report Years Considered
Figure 11. Global Human Alpha1-Proteinase Inhibitor Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Alpha1-Proteinase Inhibitor Revenue 2018-2029 (US$ Million)
Figure 13. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2018-2029)
Figure 15. Global Human Alpha1-Proteinase Inhibitor Sales 2018-2029 ((K Units)
Figure 16. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Human Alpha1-Proteinase Inhibitor Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Human Alpha1-Proteinase Inhibitor Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Human Alpha1-Proteinase Inhibitor Sales YoY (2018-2029) & (K Units)
Figure 22. China Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Human Alpha1-Proteinase Inhibitor Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Human Alpha1-Proteinase Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Alpha1-Proteinase Inhibitor in the World: Market Share by Human Alpha1-Proteinase Inhibitor Revenue in 2022
Figure 29. Global Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
Figure 31. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 32. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
Figure 33. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2018-2029)
Figure 39. US & Canada Human Alpha1-Proteinase Inhibitor Sales Share by Country (2018-2029)
Figure 40. U.S. Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 42. Mexico Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
Figure 44. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 45. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
Figure 46. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 47. Europe Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2018-2029)
Figure 48. Europe Human Alpha1-Proteinase Inhibitor Sales Share by Country (2018-2029)
Figure 49. Germany Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 50. France Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 51. UK Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 54. China Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
Figure 55. China Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 56. China Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
Figure 57. China Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 58. Asia Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
Figure 59. Asia Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 60. Asia Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
Figure 61. Asia Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 62. Asia Human Alpha1-Proteinase Inhibitor Revenue Share by Region (2018-2029)
Figure 63. Asia Human Alpha1-Proteinase Inhibitor Sales Share by Region (2018-2029)
Figure 64. Japan Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 68. India Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Share by Country (2018-2029)
Figure 75. Brazil Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Human Alpha1-Proteinase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 80. Human Alpha1-Proteinase Inhibitor Value Chain
Figure 81. Human Alpha1-Proteinase Inhibitor Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed